In this study we used an RNAi approach to identify MYC-dependent breast cancer cell lines and then inhibited CDKs including CDK4/6, CDK2 and CDK1 individually by either RNAi or small molecule inhibitors in both MYC-dependent and MYC-independent cells. This evidence concerns the gene CDK1 and breast cancer.